Adenovirus-Associated Central Nervous System Disease in Children

• Published in: The Journal of pediatrics 2019-02, Vol.205, p.130-137
• Main Authors: Schwartz, Kevin L., Richardson, Susan E., MacGregor, Daune, Mahant, Sanjay, Raghuram, Kamini, Bitnun, Ari
• Format: Article
• Language: English
• ISSN: 0022-3476; 1097-6833
• DOI: 10.1016/j.jpeds.2018.09.036

To characterize the spectrum and salient clinical features of adenovirus-associated neurologic disease in immunocompetent children. Previously healthy children (aged 1 month-18 years) with central nervous system (CNS) disease associated with adenovirus infection were identified via the Encephalitis Registry (1996-2016) and Microbiology Database (2000-2016) at The Hospital for Sick Children, Toronto, and by systematic review of the literature. The data were pooled and analyzed to identify the spectrum of illness, clinical outcome, and risk factors for death or neurologic impairment. Neurologic complications associated with adenovirus infection in our institution included febrile seizures, encephalitis, acute disseminated encephalomyelitis, and aseptic meningitis. A total of 48 immunocompetent children with adenovirus-associated CNS disease were included in the pooled analysis—38 from the literature and 10 from our institution. In 85% of cases, the virus was detected in the respiratory or gastrointestinal tract, but not the cerebrospinal fluid. Eighteen of the 48 (38%) patients either died or suffered permanent neurologic sequelae. Predictors of adverse outcome included younger age, coagulopathy, the absence of meningismus, serotype 2 virus, and the presence of seizures. After multivariable adjustment, only seizures remained a significant risk factor. Adenovirus is a rare cause of CNS disease in immunocompetent children. Disease spectrum is variable, ranging from mild aspetic meningitis and fully reversible encephalopathy to severe, potentially fatal, acute necrotizing encephalopathy.